These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10764840)
1. Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties. Cointe D; Béliard R; Jorieux S; Leroy Y; Glacet A; Verbert A; Bourel D; Chirat F Glycobiology; 2000 May; 10(5):511-9. PubMed ID: 10764840 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19. Park JH; Wang Z; Jeong HJ; Park HH; Kim BG; Tan WS; Choi SS; Park TH Appl Microbiol Biotechnol; 2012 Nov; 96(3):671-83. PubMed ID: 22714097 [TBL] [Abstract][Full Text] [Related]
3. Highly sialylated recombinant human erythropoietin production in large-scale perfusion bioreactor utilizing CHO-gmt4 (JW152) with restored GnT I function. Goh JS; Liu Y; Liu H; Chan KF; Wan C; Teo G; Zhou X; Xie F; Zhang P; Zhang Y; Song Z Biotechnol J; 2014 Jan; 9(1):100-9. PubMed ID: 24166780 [TBL] [Abstract][Full Text] [Related]
4. Glycosylation-modified erythropoietin with improved half-life and biological activity. Su D; Zhao H; Xia H Int J Hematol; 2010 Mar; 91(2):238-44. PubMed ID: 20131103 [TBL] [Abstract][Full Text] [Related]
5. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells. Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865 [TBL] [Abstract][Full Text] [Related]
6. Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells. Nimtz M; Martin W; Wray V; Klöppel KD; Augustin J; Conradt HS Eur J Biochem; 1993 Apr; 213(1):39-56. PubMed ID: 8477709 [TBL] [Abstract][Full Text] [Related]
7. Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production. Wang Q; Chung CY; Yang W; Yang G; Chough S; Chen Y; Yin B; Bhattacharya R; Hu Y; Saeui CT; Yarema KJ; Betenbaugh MJ; Zhang H Biotechnol J; 2019 Apr; 14(4):e1800186. PubMed ID: 30221828 [TBL] [Abstract][Full Text] [Related]
8. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Wasley LC; Timony G; Murtha P; Stoudemire J; Dorner AJ; Caro J; Krieger M; Kaufman RJ Blood; 1991 Jun; 77(12):2624-32. PubMed ID: 2043765 [TBL] [Abstract][Full Text] [Related]
9. Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase. Werner A; Horstkorte R; Glanz D; Biskup K; Blanchard V; Berger M; Bork K Biol Chem; 2012 Aug; 393(8):777-83. PubMed ID: 22944680 [TBL] [Abstract][Full Text] [Related]
10. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. Yang M; Butler M Biotechnol Prog; 2002; 18(1):129-38. PubMed ID: 11822911 [TBL] [Abstract][Full Text] [Related]
11. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry. Gong B; Burnina I; Stadheim TA; Li H J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886 [TBL] [Abstract][Full Text] [Related]
12. Development of an in vitro Bioassay for Recombinant Human Erythropoietin (rHuEPO) Based on Proliferative Stimulation of an Erythroid Cell Line and Analysis of Sialic Acid Dependent Microheterogeneity: UT-7 Cell Bioassay. Metta MK; Malkhed V; Tantravahi S; Vuruputuri U; Kunaparaju R Protein J; 2017 Apr; 36(2):112-122. PubMed ID: 28280963 [TBL] [Abstract][Full Text] [Related]
13. Glycoengineering tobacco plants to stably express recombinant human erythropoietin with different N-glycan profiles. Kittur FS; Hung CY; Zhu C; Shajahan A; Azadi P; Thomas MD; Pearce JL; Gruber C; Kallolimath S; Xie J Int J Biol Macromol; 2020 Aug; 157():158-169. PubMed ID: 32348856 [TBL] [Abstract][Full Text] [Related]
14. Structural and biological properties of erythropoietin in Xenopus laevis. Nogawa-Kosaka N; Hirose T; Kosaka N; Aizawa Y; Nagasawa K; Uehara N; Miyazaki H; Komatsu N; Kato T Exp Hematol; 2010 May; 38(5):363-72. PubMed ID: 20193733 [TBL] [Abstract][Full Text] [Related]
16. Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry. Sasaki H; Ochi N; Dell A; Fukuda M Biochemistry; 1988 Nov; 27(23):8618-26. PubMed ID: 3219367 [TBL] [Abstract][Full Text] [Related]
17. Role of glycosylation on the secretion and biological activity of erythropoietin. Delorme E; Lorenzini T; Giffin J; Martin F; Jacobsen F; Boone T; Elliott S Biochemistry; 1992 Oct; 31(41):9871-6. PubMed ID: 1390770 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells. Lee CG; Oh MJ; Park SY; An HJ; Kim JH Sci Rep; 2018 May; 8(1):7273. PubMed ID: 29740059 [TBL] [Abstract][Full Text] [Related]
19. Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Watson E; Bhide A; van Halbeek H Glycobiology; 1994 Apr; 4(2):227-37. PubMed ID: 8054720 [TBL] [Abstract][Full Text] [Related]
20. Control of rHuEPO biological activity: the role of carbohydrate. Elliott S; Egrie J; Browne J; Lorenzini T; Busse L; Rogers N; Ponting I Exp Hematol; 2004 Dec; 32(12):1146-55. PubMed ID: 15588939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]